Pulmonx Change in Accounts Payable 2019-2025 | LUNG

Pulmonx change in accounts payable from 2019 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

Pulmonx Change in Accounts Payable 2019-2025 | LUNG

Pulmonx change in accounts payable from 2019 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$48B
Doximity (DOCS)$12.7B
Tempus AI (TEM)$12.7B
Hims & Hers Health (HIMS)$9.9B
IRhythm Technologies (IRTC)$5.5B
Hinge Health (HNGE)$4.5B
Heartflow (HTFL)$2.8B
Inspire Medical Systems (INSP)$2.7B
Privia Health (PRVA)$2.7B
Phreesia (PHR)$1.9B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.7B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.5B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$662M
Zepp Health (ZEPP)$542M
Veradigm (MDRX)$535M
Standard BioTools (LAB)$489M
Talkspace (TALK)$454M
Butterfly Network (BFLY)$395M
Carlsmed (CARL)$369M
TruBridge (TBRG)$302M
Health Catalyst (HCAT)$260M
Outset Medical (OM)$248M
SOPHiA GENETICS SA (SOPH)$225M
Nyxoah SA (NYXH)$210M